(Q35585106)

9 August 2017

1 reference

title

Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections (English)

1 reference

9 August 2017

Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections (English)

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

2 April 2024

main subject

sepsis

0 references

streptococcal infection

1 reference

1

Anna Norrby-Teglund

0 references

Jessica Darenberg

3

object named as

Jessica Darenberg

1 reference

9 August 2017

Nahla Ihendyane

2

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14620155

2 April 2024

publication date

1 January 2003

1 reference

full work available at URL

9 August 2017

https://www.tandfonline.com/doi/pdf/10.1080/00365540310015944

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

2 April 2024

1 reference

9 August 2017

volume

35

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

683-689

1 reference

Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Variation of multifunctional surface binding proteins--a virulence strategy for group A streptococci?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Superantigens of gram-positive bacteria: structure-function analyses and their implications for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Identification and characterization of novel superantigens from Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Adjunctive Treatment of Streptococcal Toxic Shock Syndrome Using Intravenous Immunoglobulin: Case Report and Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Clinical presentations of soft-tissue infections and surgical site infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Streptococcal infections of skin and soft tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015944

Progress in Clinical and Biological Research

21 January 2018

8

272

339

Grundmann R

1988

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.

2 April 2024

11

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

2 April 2024

Journal of Immunology

22

89

307

Lancefield RC

1962

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections

2 April 2024

24

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome

2 April 2024

26

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Opsonic activity of commercially available standard intravenous immunoglobulin preparations.

2 April 2024

29

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy

2 April 2024

30

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals

2 April 2024

47

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

2 April 2024

Necrotising fasciitis

48

1 reference

https://api.crossref.org/works/10.1080/00365540310015944

2 April 2024

Identifiers

1 reference

9 August 2017

1 reference